Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC ... An article from: Clinical Psychiatry News Buy on Amazon
Facebook LinkedIn

Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC ... An article from: Clinical Psychiatry News

9.95 USD

Available for download now

Book Details
Author(s) Bruce Jancin
ISBN / ASIN B005EVIIVI
ISBN-13 978B005EVIIV7
Availability Available for download now
Marketplace United States 🇺🇸
Ratings & Reviews No reviews yet — be the first!

No reviews yet.

Description
This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on June 1, 2011. The length of the article is 865 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Promising AD treatments remain in pipeline: amyloid fibril antiaggregation therapy and neurotrophic agents are still under consideration.(GERIATRIC PSYCHIATRY)
Author: Bruce Jancin
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: June 1, 2011
Publisher: International Medical News Group
Volume: 39 Issue: 6 Page: 30(1)

Distributed by Gale, a part of Cengage Learning
Donate to EbookNetworking
No Prev
No Next